Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Cemiplimab: First Global ApprovalMarkham, Anthony ; Duggan, SeanDrugs (New York, N.Y.), 2018-11, Vol.78 (17), p.1841-1846 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
2 |
Material Type: Artigo
|
Galcanezumab: First Global ApprovalLamb, Yvette N.Drugs (New York, N.Y.), 2018-11, Vol.78 (16), p.1769-1775 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
3 |
Material Type: Artigo
|
Obinutuzumab: First Global ApprovalCameron, Fiona ; McCormack, Paul L.Drugs (New York, N.Y.), 2014, Vol.74 (1), p.147-154 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
4 |
Material Type: Artigo
|
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor studyDirix, Luc Y. ; Takacs, Istvan ; Jerusalem, Guy ; Nikolinakos, Petros ; Arkenau, Hendrik-Tobias ; Forero-Torres, Andres ; Boccia, Ralph ; Lippman, Marc E. ; Somer, Robert ; Smakal, Martin ; Emens, Leisha A. ; Hrinczenko, Borys ; Edenfield, William ; Gurtler, Jayne ; von Heydebreck, Anja ; Grote, Hans Juergen ; Chin, Kevin ; Hamilton, Erika P.Breast cancer research and treatment, 2018-02, Vol.167 (3), p.671-686 [Periódico revisado por pares]New York: Springer USTexto completo disponível |
|
5 |
Material Type: Artigo
|
A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthmaOh, Chad K ; Leigh, Richard ; McLaurin, Kimmie K ; Kim, Keunpyo ; Hultquist, Micki ; Molfino, Nestor ARespiratory research, 2013-09, Vol.14 (1), p.93-93, Article 93 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and humanShah, Dhaval K. ; Betts, Alison M.Journal of pharmacokinetics and pharmacodynamics, 2012-02, Vol.39 (1), p.67-86 [Periódico revisado por pares]Boston: Springer USTexto completo disponível |
|
7 |
Material Type: Artigo
|
Casirivimab/Imdevimab: First ApprovalDeeks, Emma D.Drugs (New York, N.Y.), 2021-11, Vol.81 (17), p.2047-2055 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
8 |
Material Type: Artigo
|
GNUV201, a novel human/mouse cross-reactive and low pH-selective anti-PD-1 monoclonal antibody for cancer immunotherapyKim, Hae-Mi ; Kim, Kyoung-Jin ; Lee, Kwanghyun ; Yoon, Myeong Jin ; Choih, Jenny ; Hong, Tae-Joon ; Cho, Eun Ji ; Jung, Hak-Jun ; Kim, Jayoung ; Park, Ji Soo ; Na, Hye Young ; Heo, Yong-Seok ; Park, Chae Gyu ; Park, Heungrok ; Han, Sungho ; Bae, DonggooBMC immunology, 2024-05, Vol.25 (1), p.29-29 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
Clinical Pharmacokinetics of Therapeutic Monoclonal AntibodiesKeizer, Ron J. ; Huitema, Alwin D. R. ; Schellens, Jan H. M. ; Beijnen, Jos H.Clinical pharmacokinetics, 2010-08, Vol.49 (8), p.493-507 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
10 |
Material Type: Artigo
|
Dupilumab: First Global ApprovalShirley, MattDrugs (New York, N.Y.), 2017-07, Vol.77 (10), p.1115-1121 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |